Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
According to TipRanks, Bailey is a 4-star analyst with an average return of 6.4% and a 45.63% success rate. Bailey covers the Healthcare sector, focusing on stocks such as Ramsay Health Care, Telix Pharmaceuticals, and CSL.
In addition to Morgan Stanley, CSL also received a Buy from Morgans’s Derek Jellinek in a report issued on May 12. However, on May 14, Citi maintained a Hold rating on CSL (Other OTC: CMXHF).
The company has a one-year high of A$275.79 and a one-year low of A$93.64. Currently, CSL has an average volume of 1.55M.
Based on the recent corporate insider activity of 16 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CMXHF in relation to earlier this year.
